| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PNPBP.2008.02.008 |
| P698 | PubMed publication ID | 18394768 |
| P2093 | author name string | T Wobrock | |
| M Soyka | |||
| P433 | issue | 6 | |
| P921 | main subject | substance P | Q411041 |
| pharmacotherapy | Q701216 | ||
| schizophrenia | Q41112 | ||
| P304 | page(s) | 1375-1385 | |
| P577 | publication date | 2008-02-26 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations | |
| P478 | volume | 32 |
| Q48908840 | An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses |
| Q44344819 | Aripiprazole plus topiramate in opioid-dependent patients with schizoaffective disorder: an 8-week, open-label, uncontrolled, preliminary study |
| Q47274758 | Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q45672244 | Design and clinical characteristics of a homogeneous schizophrenia pedigree sample from Tamil Nadu, India |
| Q49035384 | Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine |
| Q47302385 | Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats |
| Q37766239 | Emerging drugs to treat alcoholism |
| Q33590705 | Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse |
| Q38658672 | Pharmacological treatment of schizophrenia with comorbid substance use disorder. |
| Q38007928 | Policy and service development implications of the second Australian National Survey of High Impact Psychosis (SHIP). |
| Q28486157 | Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies |
| Q55868331 | Schizophrenia |
| Q21092358 | Schizophrenia and violence: systematic review and meta-analysis |
| Q37535189 | Substance abuse as a risk factor for violence in mental illness: some implications for forensic psychiatric practice and clinical ethics |
| Q36059843 | The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use. |
| Q33870389 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence |
| Q37820986 | The pharmacological management of violence in schizophrenia: a structured review. |
| Q35387756 | Treatment of substance abusing patients with comorbid psychiatric disorders |
| Q38395937 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio |
Search more.